OTCMKTS:MRMD MariMed (MRMD) Stock Price, News & Analysis → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free MRMD Stock Alerts $0.25 0.00 (0.00%) (As of 05/20/2024 ET) Add Compare Share Share Today's Range$0.25▼$0.2650-Day Range$0.20▼$0.3252-Week Range$0.20▼$0.55Volume959,302 shsAverage Volume431,322 shsMarket Capitalization$93.78 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Get MariMed alerts: Email Address Ad Porter & CompanyElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. About MariMed Stock (OTCMKTS:MRMD)MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature's Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby's Baked brand; and drink mix under Vibations brand. It also offers chewable cannabis-infused mint tablet under the brand Kalm Fusion; and flower, vapes, and edibles under InHouse brand. In addition, the company provides supplement, nutrient-infused fruit chews under Betty's Eddies brand and ice creams under Emack & Bolio's brand. The company licenses its brands. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.Read More MRMD Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MRMD Stock News HeadlinesMay 14, 2024 | markets.businessinsider.comAnalysts May Need To Revise Cannabis Stock Projections For 2024: 10 Companies Surpass EBITDA Estimates By $37MMay 13, 2024 | benzinga.comCannabis Chart Of The Week: Analysts React Meekly To Strong Q1'24 EarningsMay 10, 2024 | finance.yahoo.comMariMed Inc. (PNK:MRMD) Q1 2024 Earnings Call TranscriptMay 9, 2024 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: MariMed (MRMD), Trevi Therapeutics (TRVI)May 9, 2024 | finanznachrichten.deMariMed Inc.: MariMed Reports First Quarter 2024 EarningsMay 9, 2024 | msn.comMRMD Stock Earnings: MariMed Beats Revenue for Q1 2024May 9, 2024 | msn.comQ1 2024: MariMed's Revenue Rises To $37.9M, Amid Declining Gross MarginMay 9, 2024 | markets.businessinsider.comQ1 2024: MariMed's Revenue Rises To $37.9M, Shrinks Losses While Increasing Wholesale RevenueMay 8, 2024 | globenewswire.comMariMed Reports First Quarter 2024 EarningsApril 30, 2024 | msn.comCannabis Industry Leaders React To DEA's Historic Move To Reschedule CannabisApril 30, 2024 | finance.yahoo.comStatement From MariMed CEO And President Jon Levine Regarding The Drug Enforcement Administration’s Decision To Recategorize Cannabis To Schedule IIIApril 30, 2024 | globenewswire.comStatement From MariMed CEO And President Jon Levine Regarding The Drug Enforcement Administration's Decision To Recategorize Cannabis To Schedule IIIApril 26, 2024 | finance.yahoo.comMariMed closes acquisition of a dispensary in Illinois marking the company’s 5th in that stateApril 21, 2024 | msn.comCannabis Investors Share 'Chips Make Chunks' Wisdom For Business Expansion At Benzinga ConferenceApril 17, 2024 | benzinga.com'A F—ed-Up Situation,' Says MariMed CCO About How State Regulations Complicate Cannabis Edibles StrategyApril 13, 2024 | uk.investing.comMariMed Closes Acquisition of Thrive Dispensary in Casey, The Company's Fifth Illinois DispensaryApril 11, 2024 | msn.comMariMed Is On A Roll: Partners With Two Iconic Music Venues In Boston, Acquires Another Illinois Cannabis DispensaryApril 11, 2024 | finance.yahoo.comMariMed Closes Acquisition of Thrive Dispensary in Casey, The Company’s Fifth Illinois DispensaryApril 11, 2024 | finance.yahoo.comMariMed Closes Acquisition of Thrive Dispensary in Casey, The Company’s Fifth Illinois DispensaryApril 11, 2024 | globenewswire.comMariMed Closes Acquisition of Thrive Dispensary in Casey, The Company's Fifth Illinois DispensaryApril 10, 2024 | bizjournals.comMass. cannabis firm sponsors MGM Music Hall, House of BluesApril 10, 2024 | globenewswire.comMariMed Partners with Iconic Boston Music VenuesApril 10, 2024 | globenewswire.comMariMed Partners with Iconic Boston Music VenuesApril 9, 2024 | finanznachrichten.deMariMed Inc.: MariMed Closes Acquisition of Second Maryland DispensaryApril 9, 2024 | globenewswire.comMariMed Closes Acquisition of Second Maryland DispensarySee More Headlines Receive MRMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MariMed and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/15/2021Today5/21/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medicinals & botanicals Sub-IndustryN/A Current SymbolOTCMKTS:MRMD CUSIPN/A CIK1522767 Webmarimedadvisors.com Phone(617) 795-5140FaxN/AEmployees643Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.04) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-16,030,000.00 Net Margins-10.97% Pretax Margin-5.28% Return on Equity-2.75% Return on Assets-1.06% Debt Debt-to-Equity Ratio1.01 Current Ratio1.55 Quick Ratio0.73 Sales & Book Value Annual Sales$148.60 million Price / Sales0.63 Cash Flow$0.03 per share Price / Cash Flow8.76 Book Value$0.19 per share Price / Book1.32Miscellaneous Outstanding Shares375,130,000Free Float298,041,000Market Cap$93.78 million OptionableNot Optionable Beta2.75 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Jon R. Levine (Age 59)Co-Founder, CEO, Interim CFO, President, Secretary, Treasurer & Director Comp: $390.5kMr. Timothy Shaw (Age 46)Chief Operating Officer Comp: $346.62kMr. Jonathan W. Rider (Age 59)Chief Information Officer Mr. Steve Wayne WestVice President of Investor RelationsMr. Howard SchacterChief Communications OfficerMr. Ryan CrandallChief Revenue OfficerMr. Charles Holt FinnieChief Strategy OfficerMore ExecutivesKey CompetitorsJushiOTCMKTS:JUSHFFitLife BrandsNASDAQ:FTLFNatural Alternatives InternationalNASDAQ:NAIIBright GreenNASDAQ:BGXXExactusOTCMKTS:EXDIView All Competitors MRMD Stock Analysis - Frequently Asked Questions How have MRMD shares performed in 2024? MariMed's stock was trading at $0.2748 at the beginning of the year. Since then, MRMD stock has decreased by 9.0% and is now trading at $0.25. View the best growth stocks for 2024 here. Are investors shorting MariMed? MariMed saw a drop in short interest during the month of April. As of April 30th, there was short interest totaling 8,500 shares, a drop of 44.4% from the April 15th total of 15,300 shares. Based on an average daily volume of 571,000 shares, the days-to-cover ratio is currently 0.0 days. View MariMed's Short Interest. How were MariMed's earnings last quarter? MariMed Inc. (OTCMKTS:MRMD) released its earnings results on Monday, November, 15th. The company reported $0.01 earnings per share (EPS) for the quarter. The business had revenue of $33.21 million for the quarter. MariMed had a negative net margin of 10.97% and a negative trailing twelve-month return on equity of 2.75%. What guidance has MariMed issued on next quarter's earnings? MariMed issued an update on its FY 2024 earnings guidance on Wednesday, May, 8th. The company provided EPS guidance of for the period. The company issued revenue guidance of $156.0 million-$159.0 million, compared to the consensus revenue estimate of $157.4 million. What other stocks do shareholders of MariMed own? Based on aggregate information from My MarketBeat watchlists, some companies that other MariMed investors own include KushCo (KSHB), Organigram (OGI), Auxly Cannabis Group (CBWTF), CNBX Pharmaceuticals (CNBX), Supreme Cannabis (SPRWF), Pennsylvania Real Estate Investment Trust (PEI), GB Sciences (GBLX), Medical Marijuana (MJNA) and Smart Cannabis (SCNA). How do I buy shares of MariMed? Shares of MRMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:MRMD) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsDoes this make you sick?Allegiance Gold[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 Media4 Cryptos BETTER than BitcoinTrue Market InsidersBill Gates is all about this tiny $2 stockTimothy SykesThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldBill Clinton Backing Biden Replacement???The Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MariMed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.